AI assistant
Sending…
TENAX THERAPEUTICS, INC. — Director's Dealing 2016
Nov 22, 2016
34835_dirs_2016-11-22_39e3bf27-96d7-4370-af92-378ebf4c640c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TENAX THERAPEUTICS, INC. (tenx)
CIK: 0000034956
Period of Report: 2016-11-21
Reporting Person: Mitchum James P. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-21 | common stock | D | 7000 | $1.51 | Acquired | 26000 | Direct |
More from TENAX THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Share Issue/Capital Change
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
May 9
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
May 4
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22